CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	Options to purchase common stock	Common Stock		Additional Paid-in- Capital	Accumulated Deficit	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2020	[1]		88,434,754
Beginning balance at Dec. 31, 2020			$ 39,225
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of redeemable convertible preferred stock upon exercise of warrants (in shares)	[1]		4,232,947
Issuance of redeemable convertible preferred stock upon exercise of warrants			$ 58,097
Conversion of redeemable convertible preferred stock to common stock (in shares)	[1]		(92,667,701)
Conversion of redeemable convertible preferred stock to common stock			$ (97,322)
Ending balance (in shares) at Mar. 31, 2021	[1]		0
Ending balance at Mar. 31, 2021			$ 0
Beginning balance (in shares) at Dec. 31, 2020	[1]			33,327,294
Beginning balance at Dec. 31, 2020		$ (75,907)		$ 0		$ 133,468	$ (209,375)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	[1]	727,114
Issuance of common stock upon exercise of stock options		$ 190		$ 1		189
Repurchase of common stock (shares)	[1]			(220,561)
Repurchase of common stock		(43)				(43)
Vesting of early exercised stock options		438				438
Stock-based compensation expense		5,256				5,256
Net loss		(20,957)					(20,957)
Conversion of redeemable convertible preferred stock to common stock (in shares)	[1]			92,667,701
Conversion of redeemable convertible preferred stock to common stock		97,334		$ 12		97,322
Issuance of common stock upon merger and private offering, net of acquired private placement warrants of $19,377 (in shares)	[1]			34,947,657
Issuance of common stock upon merger and private offering, net of acquired private placement warrants of $19,377		272,064		$ 3		272,061
Offering costs in connection with the merger		(26,620)				(26,620)
Ending balance (in shares) at Mar. 31, 2021	[1]			161,449,205
Ending balance at Mar. 31, 2021		251,755		$ 16		482,071	(230,332)	0
Beginning balance (in shares) at Dec. 31, 2020	[1]		88,434,754
Beginning balance at Dec. 31, 2020			$ 39,225
Ending balance (in shares) at Sep. 30, 2021			0
Ending balance at Sep. 30, 2021			$ 0
Beginning balance (in shares) at Dec. 31, 2020	[1]			33,327,294
Beginning balance at Dec. 31, 2020		(75,907)		$ 0		133,468	(209,375)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(65,637)
Ending balance (in shares) at Sep. 30, 2021	[1]			161,529,449
Ending balance at Sep. 30, 2021		220,580		$ 16		495,576	(275,012)	0
Beginning balance (in shares) at Mar. 31, 2021	[1]		0
Beginning balance at Mar. 31, 2021			$ 0
Ending balance (in shares) at Jun. 30, 2021	[1]		0
Ending balance at Jun. 30, 2021			$ 0
Beginning balance (in shares) at Mar. 31, 2021	[1]			161,449,205
Beginning balance at Mar. 31, 2021		251,755		$ 16		482,071	(230,332)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense		6,154				6,154
Net loss		(32,011)					(32,011)
Vesting of early exercised stock options		104				104
Ending balance (in shares) at Jun. 30, 2021	[1]			161,449,205
Ending balance at Jun. 30, 2021		$ 226,002		$ 16		488,329	(262,343)	0
Ending balance (in shares) at Sep. 30, 2021			0
Ending balance at Sep. 30, 2021			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	[1]	186,165
Issuance of common stock upon exercise of stock options		$ 35		$ 0		35
Vesting of early exercised stock options		65				65
Stock-based compensation expense		7,147				7,147
Net loss		$ (12,669)					(12,669)
Cancellation of previously issued awards		0		105,921	[1]
Ending balance (in shares) at Sep. 30, 2021	[1]			161,529,449
Ending balance at Sep. 30, 2021		$ 220,580		$ 16		495,576	(275,012)	0
Beginning balance (in shares) at Dec. 31, 2021		0	0
Beginning balance at Dec. 31, 2021		$ 0	$ 0
Ending balance (in shares) at Mar. 31, 2022			0
Ending balance at Mar. 31, 2022			$ 0
Beginning balance (in shares) at Dec. 31, 2021		172,200,417		172,200,417
Beginning balance at Dec. 31, 2021		$ 260,700		$ 17		564,045	(303,356)	(6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				822,702
Issuance of common stock upon exercise of stock options		209				209
Issuance of common stock upon exercise of restricted stock awards - net of tax withholding (in shares)				812,491
Issuance of common stock upon exercise of restricted stock awards - net of tax withholding		(59)				(59)
Repurchase of common stock (shares)				(233,107)
Repurchase of common stock		(31)				(31)
Vesting of early exercised stock options		19				19
Stock-based compensation expense		8,750				8,750
Net loss		(32,397)					(32,397)
Other Comprehensive loss		(12)						(12)
Ending balance (in shares) at Mar. 31, 2022				173,602,503
Ending balance at Mar. 31, 2022		$ 237,179		$ 17		572,933	(335,753)	(18)
Beginning balance (in shares) at Dec. 31, 2021		0	0
Beginning balance at Dec. 31, 2021		$ 0	$ 0
Ending balance (in shares) at Sep. 30, 2022		0	0
Ending balance at Sep. 30, 2022		$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021		172,200,417		172,200,417
Beginning balance at Dec. 31, 2021		$ 260,700		$ 17		564,045	(303,356)	(6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,753,708
Net loss		$ (96,384)
Ending balance (in shares) at Sep. 30, 2022		184,190,016
Ending balance at Sep. 30, 2022		$ 205,292		$ 18		605,195	(399,740)	(181)
Beginning balance (in shares) at Mar. 31, 2022			0
Beginning balance at Mar. 31, 2022			$ 0
Ending balance (in shares) at Jun. 30, 2022			0
Ending balance at Jun. 30, 2022			$ 0
Beginning balance (in shares) at Mar. 31, 2022				173,602,503
Beginning balance at Mar. 31, 2022		237,179		$ 17		572,933	(335,753)	(18)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from at-the-market offering, net of commissions and fees of $451 and issuance costs of $546 (in shares)				6,749,344
Proceeds from at-the-market offering, net of commissions and fees of $451 and issuance costs of $546		14,022		$ 1		14,021
Issuance of common stock upon exercise of stock options (in shares)				234,241
Issuance of common stock upon exercise of stock options		45				45
Issuance of common stock upon exercise of restricted stock awards - net of tax withholding (in shares)				950,858
Issuance of common stock upon exercise of restricted stock awards - net of tax withholding		0				0
Repurchase of common stock (shares)				(57,301)
Repurchase of common stock		(12)				(12)
Vesting of early exercised stock options		52				52
Cancellation of Sense acquisition shares (in shares)				(55,130)
Cancellation of Sense acquisition shares		(358)				(358)
Stock-based compensation expense		8,119				8,119
Net loss		(28,000)					(28,000)	0
Other Comprehensive loss		(76)						(76)
Ending balance (in shares) at Jun. 30, 2022				181,424,515
Ending balance at Jun. 30, 2022		$ 230,971		$ 18		594,800	(363,753)	(94)
Ending balance (in shares) at Sep. 30, 2022		0	0
Ending balance at Sep. 30, 2022		$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from at-the-market offering, net of commissions and fees of $451 and issuance costs of $546 (in shares)				1,084,365
Proceeds from at-the-market offering, net of commissions and fees of $451 and issuance costs of $546		1,754		$ 0		1,754
Issuance of common stock upon exercise of stock options (in shares)				722,087
Issuance of common stock upon exercise of stock options		146				146
Issuance of common stock upon exercise of restricted stock awards - net of tax withholding (in shares)				975,147
Issuance of common stock upon exercise of restricted stock awards - net of tax withholding		0				0
Repurchase of common stock (shares)				(16,098)
Repurchase of common stock		(3)				(3)
Vesting of early exercised stock options		43				43
Stock-based compensation expense		8,455				8,455
Net loss		(35,987)					(35,987)	0
Other Comprehensive loss		$ (87)						(87)
Ending balance (in shares) at Sep. 30, 2022		184,190,016
Ending balance at Sep. 30, 2022		$ 205,292		$ 18		$ 605,195	$ (399,740)	$ (181)

[1] (1) The shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger (as defined in Note 1), have been retroactively restated as shares reflecting the exchange ratio of approximately 0.703 established in the Merger as described in Note 1.